Thank you doesn't seem enough for our melanoma nurses.
28 May 2021
'Sarah is more than a nurse – she’s my supporter, my confidante and my friend. Thank you just doesn’t seem enough.’ - Lauren, melanoma patient
Sarah is one of our much loved nurses who provides direct care and support for our melanoma patients throughout their treatment journey.
Our melanoma nurses care for patients across Sydney, the Riverina and in Western Australia, and provide support for patients in remote and regional areas via telehealth.
No matter what support a patient needs – from post-surgery or clinic support, to guiding through a clinical trial or support in the community – our melanoma nurses are there.
Like Sarah is to Lauren, our nurses become like family.
‘Sarah was the first person I met when I came in for treatment at Melanoma Institute Australia, and from that moment onwards I didn’t feel alone. Cancer is frightening, but Sarah has been my rock. She has been there for all my treatments and all my scans and follow-up appointments. I don’t know how I would have survived it all without her.’ - mother of two, 46 year-old Lauren Walker.
Melanoma Institute Australia has a growing network of nurses to provide support for patients with all stages of melanoma, and also to help educate and raise awareness about melanoma prevention and early detection.
Whilst our research and clinical teams are trialling new treatments to save lives from melanoma, it is our nurses who are on the front line. Quite simply, we couldn’t save lives without them.
‘It was Sarah who I called for re-assurance when I had side effects from treatment. It was Sarah who supported me when I was really unwell in hospital, and it was Sarah who shared my elation when I was told I was finally cancer free,’ - Lauren
‘Thank you just doesn’t seem enough.'
Our melanoma nurses are our unsung heroes who are critical to the care our patients receive in all of our clinics, every day. Without them, we won’t achieve our mission of zero deaths from melanoma this decade.
We need your help to continue funding them, so please donate today for the benefit of all melanoma patients, now and in the future. Any gift you can generously give this tax time will help us continue to fund our melanoma nurses.
Congratulations to Professor Richard Scolyer who was awarded the William O. Russell/Joanne Vandenberge Hill Award of Excellence in Pathology.
A Day in the Life Of... Serigne Lo, Research and BioStatistics Manager at Melanoma Institute Australia
Jay was your typical Aussie bloke – a truck driver, husband, dad and mate to many. Then he got melanoma. His cancer diagnosis turned his life upside down.
Clair faced an impossible choice – risk delivering her baby early, or delay potentially life-saving melanoma treatment
Little Madi misses her Dad. But she is determined to honour his memory and support life-saving melanoma research.
Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma
Melanoma Institute Australia has teamed up with the Toyota Country Music Festival 2018 in Tamworth!
MIA's dermatologist shares her knowledge with GPs on debunking myths and controversies on sunscreen.
Shannan Ponton thought he was invincible – he wasn’t. But his melanoma battle ended up saving more than his own life.
Researchers have demonstrated that immunotherapy is highly effective in treating a rare form of melanoma – a result that is surprising due to the nature of the tumour.
Innovation is helping to prevent melanoma developing in the first place.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.